What makes us so Uncommon?

We want to do the hitherto-undoable: selling rashers and rashers of cultivated pork at price parity.

For happy pigs and piggy banks.

Our Uncommon investors & partners



And our Uncommon sense of creativity, urgency, care, and resilience… of course.

We see science as an artistic and emotive calling.

It’s a creative realm where we break new ground using powerful, diverse talents and perspectives.

We care deeply for people, planet, and each other — that’s truly at the heart of health, and it’s our biggest motivator to achieve quality and safety.

We treat the world around us with respect, openness, and sincerity.

We are driven and focused, never letting setbacks get in the way of our ambitious goals.

We’re firm in our beliefs (not inflexible) while constantly critically assessing and improving all we do.

We are brave in our pursuit of daring solutions — delivering with precision, quality, and flair.

Moving quickly and with purpose, we make a high-quality, long-term impact, ASAP.

A healthy start…

I was brought up by my parents to realise that our health is at the centre of everything, and that without it, nothing matters. However, it was only later in life when it became really clear that the vast majority of people do not think about health on a regular basis (or at all) – whether it’s because they can’t afford to, weren’t taught better, or otherwise.

Our food system today is one of the largest threats to our health, whether through antibiotic resistance, climate change, foodborne and infectious diseases, or food security. In 2017, while looking for ways to create a positive impact on people’s health, I came across the concept of cultivated meat, and very quickly became passionate about the topic. I then founded Higher Steaks (our former name). A few years later, with my incredible co-founder Ruth coming on board, our unique strategy was refined and we built the business that we are today.

Higher Steaks has been an incredible brand name for us. However, we quickly outgrew its roots as we looked to communicate our new vision: nurturing world health with creative cell science. Health is at the centre of everything in life, and creativity is at the centre of what will make us a success. For us, real innovation lies at the exciting intersection of both.

By harnessing the creative potential of stem cells to improve the health of our world, we’re performing uncommon science for the common good. And with that, Uncommon was born.

—Benjamina Bollag, Founder and CEO

…to an Uncommon journey

2018

Taking flight

Our first product focus was foie gras, but we soon decided to switch to pork – the most widely eaten meat in the world.

2020

First patents filed

Co-founders Benjamina Bollag and Ruth Faram filed their first patent on our proprietary technology.

We created the world’s first pork belly and bacon with cultivated muscle (and with less than £200k raised – how precocious!)

We raised a £1.4M seed round led by Apollo Projects (Max and Sam Altman)

2021

Raising the steaks

More funding. This time £2.5M (again led by Apollo Projects) and £1M Innovate UK, the UK’s national innovation agency.

We filed an additional 2 patents on our proprietary technology.

2022

Proliferating potency

We expanded the team from 20 to 50, and filed the 4th patent on our proprietary technology.

2023

A fresh future

We moved into our new 15,000 sq ft HQ, complete with pilot plant, and closed our Series A led by Balderton and Lower Carbon Capital. Nice!

We officially became Uncommon – celebrating our unique perspective on the future of food.

scrollbarscrollbar
Dr. Adam Sidaway
Dr. Aderito Amaral
Dr. Ajeesh Chandrasekharan
Alexander Rimmer
Alexane Roux
Alice Baxter
Amy Farnsworth
Amy Symonds
Anna Westerhoff-Mason
Dr. Ariane Standing
Dr. Artun Sukan
Benjamina Bollag
Cameron Henn
Catriona Jamieson
Chloe Clarke
Daniel Knevitt
David Barr
David Mooney
Emily Fysh
Fabian Harrington-Poireau
Dr. Glenn Cockburn
Hannah Jackson
Ibraheem Raymode
Imaan Waqar
Isabelle Grant
Jacob Weightman
Jamie Speak
Jason De Turris
Jasmine Lau
Dr. Jennifer Man
Jonathan Pantlin-Whyte
Karen Davey
Dr. Lucas Carminatti Pantaleao
Lucille Delouere
Manasi (’Mansi’) Verma
Martin Hancock
Max Manders
Michelle Pazmino
Molly Somerton-Burns
Dr. Nicolas Dimopolous
Nikita Machacek
Patrick Thomas
Peter Ferguson
Dr. Rebecca Martin
Rebecca McDonald
Rebecca O’Pray
Dr. Rinat Nigmatullin
Robin Robinson
Dr. Rupambika Das
Dr. Ruth Faram
Dr. Ryan Snodgrass
Dr. Sagar Varankar
Samuel East
Samuel Morris
Simrun Bains
Sophie Newman
Tim Hutchison
Tom Brewer
Tricia Garay
Dr. Virginia Castilla Llorente
Wayne Bonadie
Dr. Yennifer Cortes Araya
Zoë Kirste

Our team

Explore
List

We’re seeking remarkable people to do extraordinary things.

Do you have a dash of the luminary? Do you see Picasso through the microscope? Do you have an urgent sense of daring? A Dalí-esque perspective on the world around you?

We do bold biotechnology in uncharted territory. You should do it with us.